Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 22, 2021

SELL
$42.51 - $63.78 $8,416 - $12,628
-198 Closed
0 $0
Q4 2020

Jan 27, 2021

BUY
$45.3 - $60.27 $8,969 - $11,933
198 New
198 $11,000
Q3 2020

Oct 26, 2020

SELL
$47.45 - $62.95 $4,412 - $5,854
-93 Closed
0 $0
Q2 2020

Jul 22, 2020

BUY
$46.85 - $61.05 $4,357 - $5,677
93 New
93 $5,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.64B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track High Mark Wealth Management LLC Portfolio

Follow High Mark Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Mark Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Mark Wealth Management LLC with notifications on news.